hsa04080 | Neuroactive ligand-receptor interaction | 46 | 39.3 |
hsa04062 | Chemokine signaling pathway | 37 | 34.98 |
hsa05169 | Epstein-Barr virus infection | 43 | 33.96 |
hsa04210 | Apoptosis | 33 | 33.72 |
ko04064 | NF-kappa B signaling pathway | 25 | 26.76 |
hsa04024 | cAMP signaling pathway | 31 | 23.86 |
hsa04060 | Cytokine-cytokine receptor interaction | 32 | 22.61 |
hsa05219 | Bladder cancer | 16 | 20.48 |
ko05323 | Rheumatoid arthritis | 20 | 19.89 |
hsa04630 | Jak-STAT signaling pathway | 23 | 18.52 |
hsa04611 | Platelet activation | 21 | 17.8 |
hsa04750 | inflammatory mediator regulation of trp channels | 19 | 17.21 |
ko05202 | Transcriptional misregulation in cancer | 22 | 15.95 |
hsa04072 | Phospholipase D signaling pathway | 21 | 15.67 |
hsa05014 | Amyotrophic lateral sclerosis (ALS) | 12 | 12.48 |
hsa04115 | p53 signaling pathway | 13 | 12.13 |
hsa05010 | Alzheimer's disease | 18 | 12.02 |
hsa04211 | Longevity regulating pathway | 15 | 11.82 |